-
Mylan gets green light for generic hypertension treatment
PITTSBURGH Mylan subsidiary Mylan Technologies has received final approval from the Food and Drug Administration for its hypertension treatment, the generic drug maker said.
Mylan said its clonidine transdermal system USP was approved in the 0.1 mg/day, 0.2 mg/day and 0.3 mg/day strengths. Mylan's CTS is the generic version of Boehringer Ingelheim's Catapres-TTS.
-
Personal Care Products Council supports expanded FDA role in industry oversight
WASHINGTON The Personal Care Products Council announced on July 15 that it is calling for a greater role by the Food and Drug Administration in regulatory oversight of personal care products and assessing ingredient safety.
The announcement came less than a week before the introduction of the Safe Cosmetics Act of 2010 in Congress by Reps. Jan Schakowsky, D-Ill., Ed Markey, D-Mass., and Tammy Baldwin, D-Wis.